Document Detail


Blastocyst transfer after aseptic vitrification of zygotes: an approach to overcome an impaired uterine environment.
MedLine Citation:
PMID:  23069744     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In some IVF cycles, no fresh embryo transfer in the stimulated cycle is advisable. The cryopreservation of zygotes and the transfer of blastocysts in a cryo-embryo transfer is an option to circumvent an inadequate uterine environment due to risk of ovarian hyperstimulation syndrome, inappropriate endometrium build up, endometrial polyps or uterine myomas. For this strategy, highly secure and safe cryopreservation protocols are advisable. This study describes a protocol for aseptic vitrification of zygotes that results in high survival rates and minimizes the potential risk of contamination in liquid nitrogen during cooling and long-term storage. In mouse zygotes, there was no difference in efficiency as compared with a conventional open vitrification system. In IVF patients, aseptically vitrified zygotes showed no difference in blastocyst formation rate as compared with sibling zygotes kept in fresh culture. A clinical study comprising 173 cryo-cycles with a transfer of blastocysts originating from vitrified zygotes showed an ongoing pregnancy rate of 40.9%. The live birth rate per patient was 36.8%. A combination of good clinical results and increased safety conditions due to aseptic vitrification encourages the use of cryo-embryo transfer for patients with a suboptimal uterine environment in a fresh cycle. In stimulated IVF cycles, high doses of hormones are given to stimulate multifollicular growth. One drawback of the hormonal substitution is that the uterine environment is not at the same time optimally prepared for embryo implantation. A solution, which is increasingly under discussion, is to cryopreserve the embryos obtained in the stimulated cycle and to transfer them back into the optimal uterine environment in a subsequent cryo-cycle. This procedure requires highly secure and safe cryopreservation protocols in order to ensure benefits for both pregnancy and birth rates. We have established a protocol for the vitrification of zygote-stage embryos in aseptic devices, which minimize the potential risk of contamination during cooling and storage. The vitrified zygotes showed the same blastocyst development as compared with sibling zygotes in fresh culture. A clinical study comprising 173 cryo-cycles with transfer of blastocysts originating from vitrified zygotes shows an ongoing pregnancy rate of 40.9%. The live birth rate per patient was 36.8%. A combination of good clinical results and increased safety conditions due to aseptic vitrification conditions contributes to a change in transfer strategy and encourages us to increase the cryo-embryo transfer rate for an optimal uterine environment.
Authors:
Pierre Vanderzwalmen; Nicolas H Zech; Fabien Ectors; Astrid Stecher; Bernard Lejeune; Sabine Vanderzwalmen; Barbara Wirleitner
Related Documents :
23955544 - First clinical manifestation of brugada syndrome during pregnancy.
18171404 - Methodological challenges when monitoring the diet of pregnant women in a large study: ...
22710954 - Assessment of maternal serum sialic acid levels in preterm versus term labor: a prospec...
23621424 - Validity of the diagnosis of pre-eclampsia in the medical birth registry of norway.
18066964 - Perinatal changes of circulating n-terminal pro b-type natriuretic peptide (nt-probnp) ...
22935244 - Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and pos...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-16
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  -     ISSN:  1472-6491     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-10-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Affiliation:
IVF Centers Prof. Zech-Bregenz, Römerstrasse 2, 6900 Bregenz, Austria; Centre Hospitalier Inter Régional Cavell (CHIREC), Braine-l'alleud, Bruxelles, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis.
Next Document:  The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands.